SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Svahn Johan) srt2:(2010-2014)"

Sökning: WFRF:(Svahn Johan) > (2010-2014)

  • Resultat 1-6 av 6
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Bramhagen, Ann-Cathrine, et al. (författare)
  • Factors influencing iron nutrition among one-year-old healthy children in Sweden
  • 2011
  • Ingår i: Journal of Clinical Nursing. - : Blackwell Munksgaard. - 0962-1067 .- 1365-2702. ; 20:13-14, s. 1887-1894
  • Tidskriftsartikel (refereegranskat)abstract
    • Syfte och mål. Att beskriva möjliga sociala, nutritionella och biologiska faktorer som påverkar järnintag och järnstatus bland friska ett-åriga barn i södra Sverige. Bakgrund. Järnbrist är en av de viktigaste nutritionella bristtillstånden och ökar risken för försenad mental och motorisk utveckling. Barn utgör en riskgrupp relaterat till snabb tillväxt, vilken kräver ett relativt högt järnbehov. Design. En prospektiv studie. Metod. Slumpmässigt valda ett-åriga barn (n=90) och deras föräldrar deltog. Föräldrarna besvarade ett frågeformulär med sociodemografiska data samt barnets hälsa och nutrition under det första året. Barnets totala matintag och blodprover (hemoglobin, röda blodkroppars medelcellsvolum, S-ferritin och transferrin receptorer) samlades in. Resultat. Tjugosju procent av barnen hade ett järnintag som var under de Nordiska rekommendationerna på 8 mg/dag (NNR 2004). Välling och järnberikad gröt bidrog till 64 % av barnets totala järnintag. Partiell bröstmjölksuppfödning och låg utbildning bland mödrarna correlerade negativt med järnintag från tilläggskosten. Totalt, 10.3 % (n=9) av barnen hade tömda järnförråd (S-ferritin <12 ug/l) och 2.3 % (n=2) hade järnbrist med eller utan anemi (Hb<100g/l). Konklusion. Ett-åriga barn i Sverige kan utveckla järnbrist men information om järnrik föda kan förbättra järnstatus. Relevans till kliniskt arbete. Kunskap kring vilka faktorer som kan påverka barns järnintag och järnstatus kan förbättre de råd och den utbildning kring mat från barnhälsovården för att förebygga eller upptäcka järnbrist.
  •  
3.
  • Guldevall, Karolin, et al. (författare)
  • Imaging Immune Surveillance of Individual Natural Killer Cells Confined in Microwell Arrays
  • 2010
  • Ingår i: PLOS ONE. - : Public Library of Science (PLoS). - 1932-6203. ; 5:11, s. e15453-
  • Tidskriftsartikel (refereegranskat)abstract
    • New markers are constantly emerging that identify smaller and smaller subpopulations of immune cells. However, there is a growing awareness that even within very small populations, there is a marked functional heterogeneity and that measurements at the population level only gives an average estimate of the behaviour of that pool of cells. New techniques to analyze single immune cells over time are needed to overcome this limitation. For that purpose, we have designed and evaluated microwell array systems made from two materials, polydimethylsiloxane (PDMS) and silicon, for high-resolution imaging of individual natural killer (NK) cell responses. Both materials were suitable for short-term studies (<4 hours) but only silicon wells allowed long-term studies (several days). Time-lapse imaging of NK cell cytotoxicity in these microwell arrays revealed that roughly 30% of the target cells died much more rapidly than the rest upon NK cell encounter. This unexpected heterogeneity may reflect either separate mechanisms of killing or different killing efficiency by individual NK cells. Furthermore, we show that high-resolution imaging of inhibitory synapse formation, defined by clustering of MHC class I at the interface between NK and target cells, is possible in these microwells. We conclude that live cell imaging of NK-target cell interactions in multi-well microstructures are possible. The technique enables novel types of assays and allow data collection at a level of resolution not previously obtained. Furthermore, due to the large number of wells that can be simultaneously imaged, new statistical information is obtained that will lead to a better understanding of the function and regulation of the immune system at the single cell level.
  •  
4.
  • Khorshidi, Mohammad Ali, 1981- (författare)
  • Live Single Cell Imaging and Analysis Using Microfluidic Devices
  • 2013
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • Today many cell biological techniques study large cell populations where an average estimate of individual cells’ behavior is observed. On the other hand, single cell analysis is required for studying functional heterogeneities between cells within populations. This thesis presents work that combines the use of microfluidic devices, optical microscopy and automated image analysis to design various cell biological assays with single cell resolution including cell proliferation, clonal expansion, cell migration, cell-cell interaction and cell viability tracking. In fact, automated high throughput single cell techniques enable new studies in cell biology which are not possible with conventional techniques.In order to automatically track dynamic behavior of single cells, we developed a microwell based device as well as a droplet microfluidic platform. These high throughput microfluidic assays allow automated time-lapse imaging of encapsulated single cells in micro droplets or confined cells inside microwells. Algorithms for automatic quantification of cells in individual microwells and micro droplets are developed and used for the analysis of cell viability and clonal expansion. The automatic counting protocols include several image analysis steps, e.g. segmentation, feature extraction and classification. The automatic quantification results were evaluated by comparing with manual counting and revealed a high success rate. In combination these automatic cell counting protocols and our microfluidic platforms can provide statistical information to better understand behavior of cells at the individual level under various conditions or treatments in vitro exemplified by the analysis of function and regulation of immune cells. Thus, together these tools can be used for developing new cellular imaging assays with resolution at the single cell level.To automatically characterize transient migration behavior of natural killer (NK) cells compartmentalized in microwells, we developed a method for single cell tracking. Time-lapse imaging showed that the NK cells often exhibited periods of high motility, interrupted with periods of slow migration or complete arrest. These transient migration arrest periods (TMAPs) often overlapped with periods of conjugations between NK cells and target cells. Such conjugation periods sometimes led to cell-mediated killing of target cells. Analysis of cytotoxic response of NK cells revealed that a small sub-class of NK cells called serial killers was able to kill several target cells. In order to determine a starting time point for cell-cell interaction, a novel technique based on ultrasound was developed to aggregate NK and target cells into the center of the microwells. Therefore, these assays can be used to automatically and rapidly assess functional and migration behavior of cells to detect differences between health and disease or the influence of drugs.The work presented in this thesis gives good examples of how microfluidic devices combined with automated imaging and image analysis can be helpful to address cell biological questions where single cell resolution is necessary. 
  •  
5.
  • Remberger, Mats, et al. (författare)
  • Improved survival after allogeneic hematopoietic stem cell transplantation in recent years : A single-center study
  • 2011
  • Ingår i: Biology of blood and marrow transplantation. - : Elsevier BV. - 1083-8791 .- 1523-6536. ; 17:11, s. 1688-1697
  • Tidskriftsartikel (refereegranskat)abstract
    • We analyzed the outcome of allogeneic hematopoietic stem cell transplantation (HSCT) over the past 2 decades. Between 1992 and 2009, 953 patients were treated with HSCT, mainly for a hematologic malignancy. They were divided according to 4 different time periods of treatment: 1992 to 1995, 1996 to 2000, 2001 to 2005, and 2006 to 2009. Over the years, many factors have changed considerably regarding patient age, diagnosis, disease stage, type of donor, stem cell source, genomic HLA typing, cell dose, type of conditioning, treatment of infections, use of granulocyte-colony stimulating factor (G-CSF), use of mesenchymal stem cells, use of cytotoxic T cells, and home care. When we compared the last period (2006-2009) with earlier periods, we found slower neutrophil engraftment, a higher incidence of acute graft-versus-host disease (aGVHD) of grades II-IV, and less chronic GVHD (cGHVD). The incidence of relapse was unchanged over the 4 periods (22%-25%). Overall survival (OS) and transplant-related mortality (TRM) improved significantly in the more recent periods, with the best results during the last period (2006-2009) and a 100-day TRM of 5.5%. This improvement was also apparent in a multivariate analysis. When correcting for differences between the 4 groups, the hazard ratio for mortality in the last period was 0.59 (95% confidence interval [CI]: 0.44-0.79; P < .001) and for TRM it was 0.63 (CI: 0.43-0.92; P = .02). This study shows that the combined efforts to improve outcome after HSCT have been very effective. Even though we now treat older patients with more advanced disease and use more alternative HLA nonidentical donors, OS and TRM have improved. The problem of relapse still has to be remedied. Thus, several different developments together have resulted in significantly lower TRM and improved survival after HSCT over the last few years.
  •  
6.
  • Svahn Gustafsson, Sofia (författare)
  • Characterization of HCV Protease Inhibitors : Inhibition and Interaction Studies with Applications for Drug Discovery
  • 2013
  • Doktorsavhandling (övrigt vetenskapligt/konstnärligt)abstract
    • In this thesis, different approaches based on inhibition and interactions studies, have been used to characterize inhibitors of the non-structural protein 3 (NS3) from the hepatitis C virus (HCV). This involves identification of enzyme inhibitory effects and characterization of interaction mechanisms and kinetics, as well as effects on replication in a cell based system and serum protein binding. All this information contributes to HCV drug discovery.By using an inhibition assay it was possible to evaluate the effects of NS3 protease inhibitors, tested or used in the clinic, on NS3 variants, representing different model systems often used for drug discovery. This study illustrates the importance of accounting for differences in catalytic properties in comparative analyses, for making relevant interpretations of inhibition data. An SPR biosensor-based assay expanded the first study, and provided kinetic and mechanistic information, by direct interaction analyses of the inhibitors. It revealed significant differences between the different genotypes and model systems, and provided data that can be used to better understand the efficacy of inhibitors.Additionally, novel NS3 protease inhibitors were evaluated with respect to their potential to interfere with protease activity, their sensitivity to resistant mutants and effect on HCV replication. The most potent compounds were also characterized by their bioavailability, solubility and metabolic stability. This provides information for design of improved NS3 protease inhibitors, suggesting potential peptidomimetic structures for the backbone as well as for peptide substituents. These modification strategies allowed inhibitors to be truncated and less peptide-like, still with retained inhibitory effect.A new strategy for analysis of serum protein binding, of importance for drug distribution was also developed. By defining and using the concept of binding efficiency, serum protein interactions of moderate affinity, as described by rapid kinetics, were characterized. This strategy is also applicable for analysis of low affinity interactions.Taken together, all these studies provide knowledge and strategies for HCV drug discovery, and by using this information we might take a step closer to the final goal, which is to eradicate HCV.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-6 av 6
Typ av publikation
tidskriftsartikel (4)
doktorsavhandling (2)
Typ av innehåll
refereegranskat (3)
övrigt vetenskapligt/konstnärligt (2)
populärvet., debatt m.m. (1)
Författare/redaktör
Andersson-Svahn, Hel ... (2)
Conrad, Jan (1)
Högbom, Martin (1)
Ackefors, Malin (1)
Nordlund, Christer, ... (1)
Watz, Emma (1)
visa fler...
Remberger, Mats (1)
Hägglund, Hans (1)
Mattsson, Jonas (1)
Uhlin, Michael (1)
Ringden, Olle (1)
Ljungman, Per (1)
Khorshidi, Mohammad ... (1)
Axelsson, Irene (1)
Manneberg, Otto (1)
Wiklund, Martin (1)
Berglund, Sofia (1)
Winiarski, Jacek (1)
Ingelsson, Erik (1)
Olsson, Richard (1)
Carlborg, Örjan (1)
Sparr, Emma (1)
Frisk, Thomas (1)
Lindskog, Maria (1)
Eklund, Per (1)
Åkerman, Johan (1)
Arrhenius, Gustaf (1)
Karlsson, Helen (1)
Larsson, Jonas (1)
Pohl, Annika (1)
Wernerson, Annika (1)
Hassan, Moustapha (1)
Broberger, Christian (1)
Dahllöf, Göran (1)
Hallström, Inger (1)
Zetterberg, Henrik (1)
Bramhagen, Ann-Cathr ... (1)
Granéli, Annette (1)
Bäckhed, Fredrik (1)
Dacke, Marie (1)
Forssén, Christian (1)
Fülöp, Tünde (1)
Kragic Jensfelt, Dan ... (1)
Lindahl, Jonas (1)
Önfelt, Björn (1)
Le Blanc, Katarina (1)
Wikman, Agneta (1)
Marschall, Hanns-Ulr ... (1)
Gustafsson, Britt (1)
Lindström, Sara (1)
visa färre...
Lärosäte
Kungliga Tekniska Högskolan (2)
Uppsala universitet (2)
Karolinska Institutet (2)
Umeå universitet (1)
Lunds universitet (1)
Malmö universitet (1)
Språk
Engelska (5)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (3)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy